In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
about
Vascular endothelial growth factor-B in physiology and diseaseMapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stabilityVascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.Placenta growth factor: potential role in pregnancy.VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.Angiogenic dysfunction in molar pregnancy.The vascular endothelial growth factor family: signalling for vascular development.Redox systems of the cell: possible links and implications.Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-AChallenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expressionDecidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding.Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis.A mouse model of the cornea pocket assay for angiogenesis studyPlacenta growth factor expression is correlated with survival of patients with colorectal cancer.PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge.Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment.Biomarkers in acute coronary syndromes and their role in diabetic patients.Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study.NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.Vascular endothelial growth factor C induces angiogenesis in vivo.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.Vascular endothelial growth factor is increased in patients with preeclampsia.Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway.Apoptotic mechanisms in the pathogenesis of COPDGene Expression Profiling Identifies Cell Proliferation and Inflammation as the Predominant Pathways Regulated by Aryl Hydrocarbon Receptor in Primary Human Fetal Lung Cells Exposed to Hyperoxia.Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.In vivo properties of the proangiogenic peptide QKEndothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.Novel aspects of corneal angiogenic and lymphangiogenic privilege.Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression.Pattern formation during vasculogenesisPlGF: a multitasking cytokine with disease-restricted activity.Endothelial cell motility, coordination and pattern formation during vasculogenesisPlacental growth factor in cancer.Placenta growth factor is a survival factor for human malignant mesothelioma cells.Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes.Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.
P2860
Q27003400-B21B174B-EE16-48FF-82F2-8D3DA628C847Q28260756-0DA5AD65-A423-472F-A6E8-FCAF3F7DE0E8Q30636178-D3D35345-4329-4AFF-B726-A8BD667F00C6Q33546314-EE7FF0AE-A519-4BB4-887E-ED523F90EEB1Q33640270-7EDBF57E-367C-4641-A14B-A1DF72228FF0Q33703272-11AED5DC-3482-4C7F-BE30-88B3B496FEB7Q33737967-46B25B60-981C-4932-A590-52AFB6D6806DQ34074762-94AFA8D4-67FA-49A7-91C0-69167A56275BQ34331369-013CAFBA-9B9A-44B7-9C32-ADAAD16BADCFQ34337865-2E7185CB-70D6-4629-A728-15398277925CQ34346660-B1D52B12-DA2F-4101-AEC2-3E0869F208C4Q34762864-FD119045-0BBA-409F-A44F-ABFA61B02CF1Q34996476-4C97DF60-435C-47B5-A52B-FA0032F4123DQ35554383-EDE8A28E-3CC6-4EA6-9DF0-77645E44FB28Q35597339-1EC46642-0E37-4C52-B4CD-22B9A22D6519Q35866840-586A6E55-8884-4B4C-B0C1-24B29661C989Q36087693-3291E437-AE34-4B46-8D0A-8A0DD2F26C40Q36333917-C88E4AD8-4FA3-4992-8CF4-ECD14294714AQ36394496-8AA9C4BA-FDCA-42ED-A7BF-A1A9558CD5E9Q36414332-D013C816-13B3-4118-87CD-69841A64647EQ36535215-F914B9DA-1A25-400C-B957-6C24DB159818Q36734917-AAAFC783-75D8-4B2D-8E68-39778E582D42Q36808641-D9338420-4F67-4F0F-AC34-1325A19283F3Q36846096-7B23E9F1-4AC7-4DFA-AD61-6AD7A83F8F25Q36888688-68618E40-9980-4A21-9923-AEF139BE38EAQ36992647-DCC193A5-6117-4841-80EA-2B3B0EE7BE24Q37018909-31ABF7E9-11DE-449B-A986-3A23090E2350Q37041894-00282C64-869A-43B9-B69F-F711C8D21CECQ37117805-A81E1EB1-F4BC-4FB3-8DC9-EFD925A37D5FQ37242381-3591A16D-BA8F-404C-AE0E-3990502B965DQ37623450-71301938-5868-4626-A1DF-85FDF2F4AD80Q37681157-CE0EE64E-AC7B-47A0-806F-8F6802A1DCB5Q37688061-511E209B-0736-4413-8424-FCE83136D51DQ38018289-BC762F29-841E-4EDE-A1FE-356D7E1B1962Q38036234-5B59E01C-CDAE-4280-B83F-200ED7040DEFQ38121852-51D59E94-3078-4E99-83E9-280076D8ED75Q38258289-718BC26A-9E22-4236-A83C-1248287D153CQ39841354-E6693663-AE96-42CE-865F-1ADDE6744159Q41051300-117A3310-A7C9-45EC-9897-B5A60A12CC3FQ41089394-6F7E6BEE-F932-4B89-AEF7-BED2E4AD3995
P2860
In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo angiogenic activity an ...... ular endothelial growth factor
@en
In vivo angiogenic activity an ...... lar endothelial growth factor.
@nl
type
label
In vivo angiogenic activity an ...... ular endothelial growth factor
@en
In vivo angiogenic activity an ...... lar endothelial growth factor.
@nl
prefLabel
In vivo angiogenic activity an ...... ular endothelial growth factor
@en
In vivo angiogenic activity an ...... lar endothelial growth factor.
@nl
P2093
P2860
P356
P1476
In vivo angiogenic activity an ...... ular endothelial growth factor
@en
P2093
P2860
P304
P356
10.1172/JCI119069
P407
P577
1996-12-01T00:00:00Z